Since 2007 the EuroMAbNet has been organising annual meetings of experts in the different disciplines of antibody production and validation across Europe. These meetings provide an arena in which participants can exchange knowledge, share cutting-edge methodology and create common strategies to standardise and improve antibody production.
Horizon Discovery presented "Harnessing CRISPR technology for production of Knock out and Knock in cell lines at scale".
If you would like to learn more about what we presented and discussed at the EuroMAbNet Meeting, please get in touch.